Your browser doesn't support javascript.
loading
Development of an ubiquitin-proteasome system signature for predicting prognosis and providing therapeutic guidance for patients with triple-negative breast cancer.
Chen, Xiaoqing; Ren, Chongyang; Zhou, Zhisheng; Chen, Jiewen; Fan, Xulong; Li, Xiangzhi; Chen, Jintao; Zhu, Jing.
Afiliação
  • Chen X; Department of Breast Medicine, Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China.
  • Ren C; Department of Breast Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Zhou Z; Department of Breast Medicine, Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China.
  • Chen J; Department of Breast Medicine, Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China.
  • Fan X; Department of Breast Medicine, Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China.
  • Li X; Department of Breast Medicine, Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China.
  • Chen J; Department of Breast Medicine, Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China.
  • Zhu J; Department of Breast Medicine, Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China.
J Gene Med ; 26(1): e3584, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37605934

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complexo de Endopeptidases do Proteassoma / Neoplasias de Mama Triplo Negativas Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complexo de Endopeptidases do Proteassoma / Neoplasias de Mama Triplo Negativas Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article